Filing Details
- Accession Number:
- 0001209191-13-050003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-31 16:09:12
- Reporting Period:
- 2013-10-29
- Filing Date:
- 2013-10-31
- Accepted Time:
- 2013-10-31 16:09:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1453943 | Thomas Connolly | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge, MA 02139 | Svp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-10-29 | 938 | $53.74 | 5,940 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-10-29 | 100 | $72.68 | 5,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-10-29 | 1,000 | $75.00 | 4,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-10-29 | 588 | $75.50 | 4,252 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-10-29 | 938 | $0.00 | 938 | $53.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,250 | 2022-09-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 150 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $75.00 (range $74.32 to $75.24).
- Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $75.50 (range $75.39 to $75.60).
- The option vests in 16 quarterly installments from 09/04/2012.
Billionaire Hedge Funds
